• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing

Johnson & Johnson: Key Points to Watch on the Charts

The stock has been bouncing off the 200-day moving average line.
By BRUCE KAMICH
Jul 01, 2019 | 03:14 PM EDT
Stocks quotes in this article: JNJ

Johnson & Johnson (JNJ) made a new high for the move up last month but overall it continues to struggle. What key chart points should we pay attention to? Let's check.

In this daily bar chart of Action Alerts PLUS holding JNJ, below, we can see that the price of the stock has been bouncing off the 200-day moving average line. In late May and early June JNJ broke below the line but quick rallied back above it. The next test of the line may not be so lucky.

Currently the On-Balance-Volume (OBV) line has been weakening and the Moving Average Convergence Divergence (MACD) oscillator has crossed to the downside for a take profits sell signal.

In the weekly bar chart of JNJ, below, we can see that the slope of the 40-week moving average line has begun to roll over and the weekly OBV line did not confirm last month's new high.

The weekly MACD oscillator is close to a crossover so the price action from here will be important.

In this Point and Figure chart of JNJ, below, we can see a potential upside price target of $169 but a decline below the June low around $130 will be bearish.

Bottom-line strategy: You can watch the latest trial against JNJ in Oklahoma on Court TV, but I would rather watch the charts. The trial and the decision are still up in the air but the charts are looking shaky.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

Action Alerts PLUS, which Cramer manages as a charitable trust, is long JNJ.

TAGS: Investing | Technical Analysis | Healthcare | Pharmaceuticals

More from Investing

These 2 Crown Jewels of the Electric Vehicle Industry Remain Private

Timothy Collins
Jan 20, 2021 12:10 PM EST

They are Rivian and Lucid, with Chanje close behind.

It's Not All Fun and GameStop

Bruce Kamich
Jan 20, 2021 11:45 AM EST

The charts of GME still look risky to me, and here's the price I'm watching.

Nasdaq Reclaims Its Uptrend

Guy Ortmann
Jan 20, 2021 11:00 AM EST

Market psychology and valuation continue to show warning signs.

3M and Mastercard Continue to Trade Sideways

Bruce Kamich
Jan 20, 2021 10:55 AM EST

Both stocks may eventually do better when investors sense that the economy is indeed going to do better.

The Market Trend Is Still Our Friend

James "Rev Shark" DePorre
Jan 20, 2021 10:36 AM EST

The folks that are waiting for the market collapse are going to have to keep waiting.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 11:38 AM EST CHRIS VERSACE

    Best Stocks to Buy for the Biden Presidency

    President-elect Biden's massive stimulus plan, int...
  • 08:07 AM EST GARY BERMAN

    Wednesday Morning Fibocall for 1/20/2021

    SPX (Long-Term View) The 1/8/21 high @ 3826.69 i...
  • 11:09 AM EST GARY BERMAN

    Is Copper About to Turn to Rust?

    Below is a very long-term copper chart.  As you...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login